| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |